<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>1 </plain></SENT>
<SENT sid="1" pm="."><plain>The epsilon 4 allele of the <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> E gene increases the risk of <z:hpo ids='HP_0003584'>late onset</z:hpo> familial and <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:hpo ids='HP_0002511'>Alzheimer disease</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Relation of epsilon 4 allele of the <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> E gene to various types of <z:hpo ids='HP_0000726'>dementia</z:hpo> and the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:hpo ids='HP_0000726'>dementia</z:hpo> were analyzed in the present study </plain></SENT>
<SENT sid="3" pm="."><plain>2 </plain></SENT>
<SENT sid="4" pm="."><plain>The study comprised 139 patients (50 men and 89 women) with <z:hpo ids='HP_0000726'>dementia</z:hpo>, mean age 73.61 years (range 47-98) </plain></SENT>
<SENT sid="5" pm="."><plain>The diagnosis of <z:hpo ids='HP_0000726'>dementia</z:hpo> was made according to Diagnostic and Statistical Manual of <z:e sem="disease" ids="C0004936" disease_type="Mental or Behavioral Dysfunction" abbrv="">Mental Disorders</z:e>, and subtypes diagnoses were made according to NINCDS-ADRDA and NINDS-AIREN criteria </plain></SENT>
<SENT sid="6" pm="."><plain>Minimental State Examination (MMSE) was used for the screening of <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="0" ids="39015">Apolipoprotein</z:chebi> E polymorphism was determined by the PCR-RFLP technique-polymerase chain reaction and subsequent digestion with specific restriction endonuclease </plain></SENT>
<SENT sid="8" pm="."><plain>For statistical analyses chi-square test and the crude Gart s odds ratio (OR) and 95% confidence intervals (CI) were used </plain></SENT>
<SENT sid="9" pm="."><plain>3 </plain></SENT>
<SENT sid="10" pm="."><plain>From 139 <z:hpo ids='HP_0000726'>dementia</z:hpo> patients (MMSE &lt; or =24 points) in 61 (45%) <z:hpo ids='HP_0002511'>Alzheimer disease</z:hpo> (AD) was present, in 44 patients (31%) vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VD), and in 34 (24%) mixed <z:hpo ids='HP_0000726'>dementia</z:hpo> (MD) were revealed </plain></SENT>
<SENT sid="11" pm="."><plain>In comparison with control group the presence of at least one ApoE-varepsilon4 allele was significantly higher only in the group with AD (p &lt; 0.001), (OR=2.76; 95%: 1.42-5.36) </plain></SENT>
<SENT sid="12" pm="."><plain>The frequency of epsilon4 allele carriers was significantly overrepresented in AD group compared with VD (chi(2)=5.94; p=0.0148) </plain></SENT>
<SENT sid="13" pm="."><plain>Differences between AD and MD or VD and MD were not confirmed </plain></SENT>
</text></document>